Photo from ASCO/X
Jun 27, 2024, 15:26
Diwakar Davar and Jason Luke discuss high-risk melanoma from the NADINA trial
The American Society of Clinical Oncology (ASCO) shared on X:
“Diwakar Davar and Jason Luke of UPMC Hillman Cancer Center discuss exciting advances in high-risk melanoma from the NADINA trial and other emerging approaches in immunotherapy from ASCO24 on the ASCO Daily News Podcast.”
Source: ASCO/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 13:29
Feb 21, 2025, 13:07
Feb 21, 2025, 13:06
Feb 21, 2025, 13:03
Feb 21, 2025, 13:00
Feb 21, 2025, 12:53
Feb 21, 2025, 12:41
Feb 21, 2025, 12:39